Marina Ziche
#166,799
Most Influential Person Now
Researcher
Marina Ziche's AcademicInfluence.com Rankings
Marina Zichecomputer-science Degrees
Computer Science
#10083
World Rank
#10576
Historical Rank
Machine Learning
#4587
World Rank
#4638
Historical Rank
Artificial Intelligence
#4948
World Rank
#5012
Historical Rank
Database
#7038
World Rank
#7282
Historical Rank
Download Badge
Computer Science
Marina Ziche's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science Stanford University
- Bachelors Computer Science Stanford University
Similar Degrees You Can Earn
Why Is Marina Ziche Influential?
(Suggest an Edit or Addition)Marina Ziche's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth (1992) (1350)
- Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. (1997) (956)
- Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. (1994) (865)
- VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. (1998) (532)
- A novel vascular endothelial growth factor encoded by Orf virus, VEGF‐E, mediates angiogenesis via signalling through VEGFR‐2 (KDR) but not VEGFR‐1 (Flt‐1) receptor tyrosine kinases (1999) (532)
- Nitric Oxide Is an Upstream Signal of Vascular Endothelial Growth Factor-induced Extracellular Signal-regulated Kinase½ Activation in Postcapillary Endothelium* (1998) (464)
- VEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant (2004) (463)
- Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. (1996) (455)
- Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. (1998) (435)
- Role of prostaglandin E1 and copper in angiogenesis. (1982) (413)
- Induction of inflammatory angiogenesis by monocyte chemoattractant protein‐1 (1999) (333)
- Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic. (1997) (313)
- In vitro and in vivo activation of endothelial cells by colony-stimulating factors. (1991) (311)
- c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. (1999) (295)
- Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells. (1995) (289)
- An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis. (1997) (280)
- Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells. (1990) (266)
- Nitric Oxide and Angiogenesis (2000) (245)
- Ceruloplasmin, copper ions, and angiogenesis. (1982) (234)
- Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF. (1997) (225)
- Luteolin Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis; Inhibition of Endothelial Cell Survival and Proliferation by Targeting Phosphatidylinositol 3′-Kinase Activity (2004) (206)
- Interleukin 1 is an autocrine regulator of human endothelial cell growth. (1990) (197)
- Analysis of the role of chemokines in angiogenesis. (2003) (191)
- HIV-tat protein is a heparin-binding angiogenic growth factor. (1996) (175)
- VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. (1998) (170)
- Role of nitric oxide in the modulation of angiogenesis. (2003) (161)
- The bradykinin/B1 receptor promotes angiogenesis by up‐regulation of endogenous FGF‐2 in endothelium via the nitric oxide synthase pathway (2001) (159)
- The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo (2000) (157)
- The heparin binding 25 kDa fragment of thrombospondin‐1 promotes angiogenesis and modulates gelatinase and TIMP‐2 production in endothelial cells (2000) (149)
- Nitric oxide promotes DNA synthesis and cyclic GMP formation in endothelial cells from postcapillary venules. (1993) (133)
- Proliferation and migration of endothelial cells is promoted by endothelins via activation of ETB receptors. (1995) (131)
- The effect of hydroxyapatite nanocrystals on microvascular endothelial cell viability and functions. (2006) (121)
- Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases. (1996) (119)
- The activin-binding protein follistatin regulates autocrine endothelial cell activity and induces angiogenesis. (1997) (118)
- Prostaglandin E2 Regulates Angiogenesis via Activation of Fibroblast Growth Factor Receptor-1* (2008) (115)
- NK1‐receptors mediate the proliferative response of human fibroblasts to tachykinins (1990) (115)
- Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells. (1988) (104)
- Angiogenesis and neoplastic progression in vitro. (1982) (98)
- EP2 prostanoid receptor promotes squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1/2 pathways (2007) (95)
- B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF‐2 effects (1998) (95)
- Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10. (2000) (95)
- Gangliosides promote the angiogenic response. (1989) (94)
- Interferon-alpha and interleukin 2 synergistically enhance basic fibroblast growth factor synthesis and induce release, promoting endothelial cell growth. (1993) (93)
- I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo. (2000) (91)
- Role of soluble mediators in angiogenesis. (1996) (88)
- Functional and pharmacological characterization of a VEGF mimetic peptide on reparative angiogenesis. (2012) (88)
- Simulated hypogravity impairs the angiogenic response of endothelium by up-regulating apoptotic signals. (2005) (87)
- Inhibitory effect of full-length human endostatin on in vitro angiogenesis. (1999) (85)
- Angiogenesis can be stimulated or repressed in vivo by a change in GM3:GD3 ganglioside ratio. (1992) (82)
- Aminoflavone, a ligand of the aryl hydrocarbon receptor, inhibits HIF-1alpha expression in an AhR-independent fashion. (2010) (80)
- Development of new drugs in angiogenesis. (2004) (79)
- Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin. (2003) (76)
- Purine analogue 6-methylmercaptopurine riboside inhibits early and late phases of the angiogenesis process. (1999) (75)
- Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers (2003) (75)
- VEGF induces signalling and angiogenesis by directing VEGFR2 internalisation through macropinocytosis (2016) (74)
- Aß peptides accelerate the senescence of endothelial cells in vitro and in vivo, impairing angiogenesis (2010) (73)
- Cell-Mediated Delivery of Fibroblast Growth Factor-2 and Vascular Endothelial Growth Factor onto the Chick Chorioallantoic Membrane: Endothelial Fenestration and Angiogenesis (2001) (73)
- Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures. (1999) (73)
- The natural compound n-butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivo (2011) (73)
- Divergent effects of quercetin conjugates on angiogenesis (2006) (72)
- Interaction of high‐molecular‐weight basic fibroblast growth factor with endothelium: Biological activity and intracellular fate of human recombinant Mr 24,000 bFGF (1994) (71)
- N-myc oncogene overexpression down-regulates IL-6; evidence that IL-6 inhibits angiogenesis and suppresses neuroblastoma tumor growth (2002) (71)
- Chronic viral hepatitis induced by hepatitis C but not hepatitis B virus infection correlates with increased liver angiogenesis (1997) (69)
- Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor. (1998) (69)
- Constitutive and inducible nitric oxide synthase: role in angiogenesis. (2002) (67)
- Inhibition of Hypoxia Inducible Factor-1α by Dihydroxyphenylethanol, a Product from Olive Oil, Blocks Microsomal Prostaglandin-E Synthase-1/Vascular Endothelial Growth Factor Expression and Reduces Tumor Angiogenesis (2010) (67)
- Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis. (2011) (62)
- Molecular regulation of tumour angiogenesis by nitric oxide. (2009) (61)
- Role of nitric oxide in tumor angiogenesis. (2004) (61)
- Hepatocyte growth factor and inducible nitric oxide synthase are involved in multidrug resistance-induced angiogenesis in hepatocellular carcinoma cell lines. (2006) (59)
- Nanostructured HA crystals up-regulate FGF-2 expression and activity in microvascular endothelium promoting angiogenesis. (2007) (59)
- Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells (2018) (59)
- Hydroxytyrosol, a product from olive oil, reduces colon cancer growth by enhancing epidermal growth factor receptor degradation. (2016) (57)
- Antiproliferative activity of new 1-aryl-4-amino-1H-pyrazolo[3,4-d]pyrimidine derivatives toward the human epidermoid carcinoma A431 cell line. (2004) (57)
- Substance P induces migration of capillary endothelial cells: a novel NK-1 selective receptor mediated activity. (1991) (56)
- Peroxynitrite inactivates human‐tissue inhibitor of metalloproteinase‐4 (2008) (56)
- Physiological levels of amyloid peptides stimulate the angiogenic response through FGF‐2 (2004) (53)
- ERK1-2 and p38 MAPK regulate MMP/TIMP balance and function in response to thrombospondin-1 fragments in the microvascular endothelium. (2004) (52)
- Protective effect of 4-coumaric acid from UVB ray damage in the rabbit eye. (2009) (51)
- Prostaglandin E2 Primes the Angiogenic Switch via a Synergic Interaction With the Fibroblast Growth Factor-2 Pathway (2009) (50)
- Mitochondrial aldehyde dehydrogenase-2 activation prevents &bgr;-amyloid-induced endothelial cell dysfunction and restores angiogenesis (2013) (50)
- Antagonism of Bradykinin B2 Receptor Prevents Inflammatory Responses in Human Endothelial Cells by Quenching the NF-kB Pathway Activation (2014) (48)
- deltaPKC inhibition or varepsilonPKC activation repairs endothelial vascular dysfunction by regulating eNOS post-translational modification. (2010) (46)
- Soluble N-cadherin fragment promotes angiogenesis (2006) (45)
- Effects of substance P on mesenteric lymphatic contractility in the rat. (2004) (45)
- Pharmacological Inhibition of Microsomal Prostaglandin E Synthase-1 Suppresses Epidermal Growth Factor Receptor-Mediated Tumor Growth and Angiogenesis (2012) (44)
- Synergism between gangliosides and basic fibroblastic growth factor in favouring survival, growth, and motility of capillary endothelium (1990) (43)
- Pyrazolo–pyrimidine‐derived c‐Src inhibitor reduces angiogenesis and survival of squamous carcinoma cells by suppressing vascular endothelial growth factor production and signaling (2006) (41)
- Growth advantage and vascularization induced by basic fibroblast growth factor overexpression in endometrial HEC-1-B cells: an export-dependent mechanism of action. (1995) (40)
- Fibroblast Growth Factor-2 Mediates Angiotensin-Converting Enzyme Inhibitor-Induced Angiogenesis in Coronary Endothelium (2006) (40)
- Exogenous BH4/Bcl-2 Peptide Reverts Coronary Endothelial Cell Apoptosis Induced by Oxidative Stress (2004) (40)
- Dutch and Arctic mutant peptides of beta amyloid(1-40) differentially affect the FGF-2 pathway in brain endothelium. (2009) (39)
- The Syndecan-4/Protein Kinase Cα Pathway Mediates Prostaglandin E2-induced Extracellular Regulated Kinase (ERK) Activation in Endothelial Cells and Angiogenesis in Vivo* (2013) (38)
- Activation of MAPKs in proximal tubule cells from spontaneously hypertensive and control Wistar-Kyoto rats. (2000) (36)
- Sulfhydryl Angiotensin-Converting Enzyme Inhibitor Promotes Endothelial Cell Survival through Nitric-Oxide Synthase, Fibroblast Growth Factor-2, and Telomerase Cross-Talk (2010) (35)
- Common Protective Strategies in Neurodegenerative Disease: Focusing on Risk Factors to Target the Cellular Redox System (2020) (35)
- FGF-2 overexpression opposes the beta amyloid toxic injuries to the vascular endothelium (2006) (35)
- Substance P increases cyclic GMP levels on coronary postcapillary venular endothelial cells. (1993) (34)
- mPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity (2015) (34)
- Growth and motility of microvascular endothelium are modulated by the relative concentration of gangliosides in the medium (1992) (33)
- Plasminogen activators (urokinase) mediate neovascularization: possible role in tumor angiogenesis. (1986) (33)
- H2S dependent and independent anti-inflammatory activity of zofenoprilat in cells of the vascular wall. (2016) (32)
- A proangiogenic peptide derived from vascular endothelial growth factor receptor-1 acts through alpha5beta1 integrin. (2008) (32)
- PGE2/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells (2017) (32)
- The sulphydryl containing ACE inhibitor Zofenoprilat protects coronary endothelium from Doxorubicin-induced apoptosis. (2013) (32)
- Characterization of zofenoprilat as an inducer of functional angiogenesis through increased H2S availability (2015) (31)
- The tachykinin NK1 receptor mediates the migration-promoting effect of substance P on human skin fibroblasts in culture (1996) (31)
- The soluble guanylyl cyclase inhibitor NS-2028 reduces vascular endothelial growth factor-induced angiogenesis and permeability. (2010) (31)
- PKCε activation promotes FGF-2 exocytosis and induces endothelial cell proliferation and sprouting. (2013) (30)
- EGFR signaling upregulates expression of microsomal prostaglandin E synthase-1 in cancer cells leading to enhanced tumorigenicity (2012) (29)
- Molecular and cellular basis of myocardial angiogenesis. (1994) (28)
- Prostaglandin E2 transactivates the colony‐stimulating factor‐1 receptor and synergizes with colony‐stimulating factor‐1 in the induction of macrophage migration via the mitogen‐activated protein kinase ERK1/2 (2015) (27)
- ALDH3A1 Overexpression in Melanoma and Lung Tumors Drives Cancer Stem Cell Expansion, Impairing Immune Surveillance through Enhanced PD-L1 Output (2019) (26)
- Inhibition of cell cycle progression by the hydroxytyrosol–cetuximab combination yields enhanced chemotherapeutic efficacy in colon cancer cells (2017) (26)
- The isoflavone metabolite 6-methoxyequol inhibits angiogenesis and suppresses tumor growth (2012) (26)
- Cu(II) and Zn(II) complexes with hyaluronic acid and its sulphated derivative. Effect on the motility of vascular endothelial cells. (2000) (25)
- Formulation of liposomes functionalized with Lotus lectin and effective in targeting highly proliferative cells. (2017) (25)
- Endothelial cell migration is induced by soluble P-selectin. (1997) (25)
- Prevention of ischemic brain injury by treatment with the membrane penetrating apoptosis inhibitor, TAT-BH4 (2009) (25)
- Gangliosides, copper ions and angiogenic capacity of adult tissues (1990) (24)
- Linking microsomal prostaglandin E Synthase-1/PGE-2 pathway with miR-15a and −186 expression: Novel mechanism of VEGF modulation in prostate cancer (2016) (24)
- ALDH2 Activity Reduces Mitochondrial Oxygen Reserve Capacity in Endothelial Cells and Induces Senescence Properties (2018) (23)
- Linomide blocks angiogenesis by breast carcinoma vascular endothelial growth factor transfectants. (1998) (23)
- Targeting endothelial cell metabolism for cardio-protection from the toxicity of antitumor agents (2016) (23)
- PGE2 mediates EGFR internalization and nuclear translocation via caveolin endocytosis promoting its transcriptional activity and proliferation in human NSCLC cells (2018) (22)
- Calcium entry, mobilization, and extrusion in postcapillary venular endothelium exposed to bradykinin. (1993) (22)
- Monitoring Endothelial and Tissue Responses to Cobalt Ferrite Nanoparticles and Hybrid Hydrogels (2016) (22)
- Vimentin expression influences flow dependent VASP phosphorylation and regulates cell migration and proliferation. (2010) (22)
- Nitric oxide modulates angiogenesis elicited by prostaglandin E1 in rabbit cornea. (1995) (21)
- RNA‐mediated gene silencing of FUT1 and FUT2 influences expression and activities of bovine and human fucosylated nucleolin and inhibits cell adhesion and proliferation (2010) (21)
- Targeting endothelial-to-mesenchymal transition: the protective role of hydroxytyrosol sulfate metabolite (2019) (20)
- Endostatin: A Promising Drug for Antiangiogenic Therapy (1999) (19)
- Angiogenesis and prediction of sarcoma formation by plastic. (1981) (19)
- Miniaturizing VEGF: Peptides mimicking the discontinuous VEGF receptor-binding site modulate the angiogenic response (2016) (19)
- Role of nitric oxide in the angiogenesis of avascular tissue. (1999) (18)
- Calcitonin gene-related peptide selectively increases cAMP levels in the guinea-pig ureter. (1995) (17)
- The corneal pocket assay. (2009) (17)
- New Insights Into Blood-Brain Barrier Maintenance: The Homeostatic Role of β-Amyloid Precursor Protein in Cerebral Vasculature (2020) (16)
- Bradykinin B2 Receptor Contributes to Inflammatory Responses in Human Endothelial Cells by the Transactivation of the Fibroblast Growth Factor Receptor FGFR-1 (2018) (15)
- A non-peptide NK1 receptor agonist showing subpicomolar affinity. (2004) (15)
- Cardiovascular effects of capsaicin-sensitive neurons. (1993) (14)
- Evidence of β-blockers drug repurposing for the treatment of triple negative breast cancer: A systematic review. (2019) (14)
- Quantitative RT-PCR Assay for VEGF Mrna in Human Tumors of the Kidney (1999) (14)
- Sex-tailored pharmacology and COVID-19: Next steps towards appropriateness and health equity (2021) (13)
- ANG II potentiates mitogenic effect of norepinephrine in vascular muscle cells: role of FGF-2. (2001) (13)
- A novel protein from the serum of Python sebae, structurally homologous with type-γ phospholipase A(2) inhibitor, displays antitumour activity. (2011) (13)
- A fucose-containing O-glycoepitope on bovine and human nucleolin. (2008) (13)
- Endothelial Aldehyde Dehydrogenase 2 as a Target to Maintain Vascular Wellness and Function in Ageing (2020) (12)
- How to conjugate the stemness marker ALDH1A1 with tumor angiogenesis, progression, and drug resistance (2020) (12)
- Thapsigargin inhibits the response to acetylcholine and substance P but does not interfere with the responses to endothelium-independent agents. (1996) (12)
- Nitric Oxide Releasing Metal–Diazeniumdiolate Complexes Strongly Induce Vasorelaxation and Endothelial Cell Proliferation (2008) (11)
- TAT-BH4 counteracts Abeta toxicity on capillary endothelium. (2007) (11)
- Opposite effects of beta amyloid on endothelial cell survival: role of fibroblast growth factor-2 (FGF-2). (2005) (11)
- Effect of selective tachykinin receptor antagonists on the growth of human skin fibroblasts (1993) (10)
- Copper-dependent amine oxidases in angiogenesis induced by prostaglandin E1 (PGE1). (1987) (10)
- The biological basis for antiangiogenic therapy. (2000) (10)
- Linking of mPGES-1 and iNOS activates stem-like phenotype in EGFR-driven epithelial tumor cells. (2017) (10)
- Nitric oxide donor drugs based on metallic centers (2001) (10)
- First-Line Pharmacotherapies and Survival among Patients Diagnosed with Non-Resectable NSCLC: A Real-Life Setting Study with Gender Prospective (2021) (9)
- A nanoscale fluorocarbon coating on PET surfaces improves the adhesion and growth of cultured coronary endothelial cells (2008) (9)
- Repurposing of drugs for triple negative breast cancer: an overview (2020) (9)
- The rabbit corneal pocket assay for the study of angiogenesis. (2004) (9)
- VEGF induces signalling and angiogenesis by directing VEGFR2 internalisation through macropinocytosis (2016) (9)
- [The effect of vasoactive factors on the growth of of coronary endothelial cells]. (1992) (9)
- Cooperation of heparin with other angiogenetic effectors. (1986) (9)
- Effect of the non-peptide blocker CP 96,345 on the cellular mechanism involved in the response to NK1 receptor stimulation in human skin fibroblasts (1996) (9)
- Correction to: Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells (2019) (9)
- Nitric oxide modulates the angiogenic phenotype of middle-T transformed endothelial cells. (2001) (8)
- Distinct capillary density and progression promoted by vascular endothelial growth factor-A homodimers and heterodimers (2004) (8)
- Angiogenic phenotype induced by basic fibroblast growth factor transfection in brain microvascular endothelial cells. (1996) (8)
- Distinct chemotactic and angiogenic activities of peptides derived from Kaposi's sarcoma virus encoded chemokines. (2000) (8)
- Molecular mechanisms of VEGF-induced angiogenesis (2004) (7)
- Differential contribution of bradykinin receptors in angiogenesis. (2000) (7)
- The effect of thiorphan on release of sensory neuropeptides from guinea-pig cerebral venous sinuses. (1991) (7)
- Involvement of Bradykinin B2 Receptor in Pathological Vascularization in Oxygen-Induced Retinopathy in Mice and Rabbit Cornea (2018) (7)
- Biological Parameters for the Choice of Antiangiogenic Therapy and Efficacy Monitoring (1999) (7)
- Cytokine-mediated control of endothelial cell growth: interferon-* and interleukin-2 synergistically enhance basic fibroblast growth factor synthesis and induce release, promoting cell growth in vitro and in vivo. (1993) (7)
- Hydrogen Peroxide Mediates Endothelium‐Dependent Dilation of Coronary Arterioles in Obese Rats on a Low‐Carbohydrate Diet (2013) (6)
- Activation of DNA synthesis and inositol-phosphate turnover in coronary venular endothelial cells exposed to bradykinin☆ (1992) (6)
- In vitro and in vivo models to study chemokine regulation of angiogenesis. (2004) (6)
- Influence of lithium on mammary tumor growth in vivo. (1980) (6)
- Assessing vascular senescence in zebrafish. (2013) (6)
- Therapeutic Implications of the Nitric Oxide Pathway in the Angiogenesis of Tumors and Inflammatory-Related Disorders (2019) (6)
- Vasorelaxant effects induced by the antiangiogenic drug linomide in aortic and saphenous vein preparations of the rabbit (1997) (5)
- Corneal assay for angiogenesis. (2001) (5)
- Pyridoxamine as inhibitor of the blood plasma benzylamine oxidase and other copper‐containing amine oxidases (1985) (5)
- Amyloid-β Precursor Protein APP Down-Regulation Alters Actin Cytoskeleton-Interacting Proteins in Endothelial Cells (2020) (5)
- Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells (2018) (5)
- The Rat and the Rabbit Cornea Assay (1998) (5)
- Antiangiogenic effect of linomide on breast cancer VEGF transfectants (1997) (5)
- ALDH1A1 overexpression in melanoma cells promotes tumor angiogenesis by activating the IL-8/Notch signaling cascade (2022) (5)
- Targeting PGE2 Signaling in Tumor Progression and Angiogenesis. (2014) (5)
- The Rabbit Corneal Pocket Assay. (2016) (5)
- Molecular Mechanisms of Resistance to Anti-Angiogenic Drugs. (2021) (4)
- Non-peptide NK1 receptor ligands based on the 4-phenylpyridine moiety. (2011) (4)
- mPGES-1 as a new target to overcome acquired resistance to gefitinib in non-small cell lung cancer cell lines. (2019) (4)
- Aminoflavone, a ligand of the Aryl Hydrocarbon Receptor (AhR), inhibits HIF-1 α expression in an AhR-independent fashion (2010) (4)
- Studying Vascular Angiogenesis and Senescence in Zebrafish Embryos. (2016) (4)
- Effect of SP and selective NK1 receptor agonist on inositol phosphates and cytosolic calcium levels in cultured human fibroblasts (1993) (3)
- PGE 2 / EP 3 / SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells (2017) (3)
- A proangiogenic peptide derived from vascular endothelial growth factor receptor-1 acts through α5β1 integrin (2008) (2)
- Nitric oxide mediates angiogenesis and endothelial cell growth and migration promoted by substance P (1994) (2)
- Real-World Utilization of Target- and Immunotherapies for Lung Cancer: A Scoping Review of Studies Based on Routinely Collected Electronic Healthcare Data (2021) (2)
- Real word evidence on rituximab utilization: Combining administrative and hospital-pharmacy data (2020) (2)
- Sex differences in the utilization of drugs for COVID‐19 treatment among elderly residents in a sample of Italian nursing homes (2022) (2)
- Determination of angiogenesis-regulating properties of NO. (2002) (2)
- Nitric Oxide and PGE-2 Cross-Talk in EGFR-Driven Epithelial Tumor Cells. (2016) (2)
- [An angiogenesis study of Dukes' B colonic tumors]. (1999) (2)
- The corneal pocket assay. (2015) (2)
- Basic fibroblast growth factor (b-FGF) effect on cultured human skin fibroblast is potentiated by substance P (1992) (1)
- Roles of Adenosine in Angiogenesis (1998) (1)
- Plasmin Produces Proangiogenic Fragments (2003) (1)
- Female Sexual Dysfunction in Alcohol and Drug Abuse (2017) (1)
- Effect of tachykinin selective receptor antagonists on the growth of cultured human skin fibroblasts (1992) (1)
- Risk of intraocular pressure increase with intravitreal injections of Vascular Endothelial Growth Factor Inhibitors: a cohort study. (2022) (1)
- The isoflavone metabolite 6-methoxyequol inhibits angiogenesis and suppresses tumor growth (2012) (1)
- Absence of PAF actions increases angiogenesis (2004) (1)
- The Proliferative Effect of Substance P on Capillary Endothelial Cells is Mediated by Nitric Oxide (1994) (1)
- Regulatory Events in Angiogenesis1 (1990) (1)
- Antiangiogenic drugs: Chemosensitizers for combination cancer therapy (2022) (1)
- Abstract 1137: Switch From Nitric Oxide To Hydrogen Peroxide Mediated Dilation In Coronary Arterioles Of Obese Rats (2007) (1)
- PP53 - Characterization of zofenoprilat as an inducer of functional angiogenesis through increased hydrogen sulfide availability (2015) (1)
- EP2 prostanoid receptor promotes A431 cell growth and invasion by iNOS and ERK1-2 pathways (2006) (1)
- Angiogenic Polypeptides in Breast Cancer: Expression of Mrna’s in Primary Human Tumours, MCF-7 Cell Transfection and Xenograft Models (1998) (1)
- Corneal Angiogenesis Assay (2004) (0)
- Urokinase activity and mobilization in coronary post-capillary endothelial cells exposed to nitric oxide (1995) (0)
- endothelial cell dysfunction and restores angiogenesis 2 3 (2013) (0)
- Effect of substance P and [Sar9]-SP-sulfone on cyclic GMP accumulation in cultured coronary capillary endothelial cells (1994) (0)
- Late Breaking Science posters (2016) (0)
- ROLE OF NEUROKINES MK AND FTN IN TUMORIGENESIS Angiogenesis Assay and Xenograft Experiments (2006) (0)
- Nitric Oxide in Tumor Angiogenesis (2008) (0)
- Linking regional administrative data with an hospital pathology registry in Italy to describe first-line pharmacotherapy of non-resectable non-small cell lung cancer in 2009-2017 (2020) (0)
- Chapter 17 Nitric Oxide in Tumor Angiogenesis (0)
- The Italian ‘Special Project on Angiogenesis’ (2004) (0)
- Age- and hypertension-associated changes in the vasodilating effect of CGRP in the rat mesenteric vascular bed (1993) (0)
- New tools for the study of cGMP dependent functions: validation in VEGF induced permeability and angiogenesis (2011) (0)
- Studying Angiogenesis in the Rabbit Corneal Pocket Assay. (2021) (0)
- factor receptor-1 acts through A proangiogenic peptide derived from vascular endothelial growth (2013) (0)
- Angiotensin(s) induce the release of prostacyclin and the growth of coronary venular endothelial cells (1993) (0)
- Correction to: Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells (2019) (0)
- 30 Antisense oligonucleotides against the urokinase receptor inhibit both urokinase-dependent and growth factors-dependent angiogenesis in vitro (1997) (0)
- Angiogenesis in vivo is enhanced by overexpression of vascular endothelial growth factor in MCF-7 cell line (1995) (0)
- Design of Pharmacological and Diagnostic Strategies for Angiogenesis-Dependent Diseases (2002) (0)
- Endothelin promote growth and migration of capillary endothelial cells in vitro (1990) (0)
- Preface: Focus on the Main Research Interests of Professor Natale D’Alessandro (2021) (0)
- Brief Biography of Professor Natale D’Alessandro Dedicated in His Memory (2021) (0)
- Trophic effects of neuropeptides (1992) (0)
- Cancer esearch cer Therapy : Preclinical bition of Hypoxia Inducible Factor-1 α by ydroxyphenylethanol , a Product from Olive Oil , Blocks rosomal Prostaglandin-E Synthase-1 / Vascular Endothelial R wth Factor Expression and Reduces Tumor Angiogenesis (2010) (0)
- The Urokinase Receptor-Derived Peptide UPARANT Inhibits Pathological Retinal Angiogenesis (2014) (0)
- [Coronary angiogenesis: role, modulation and prospects]. (1994) (0)
- Meeting Report The biological basis for antiangiogenic therapy (2000) (0)
- Substance P induces migration of isolated capillary endothelial cells (1990) (0)
- AF3485 inhibits tumor growth and angiogenesis. (2013) (0)
- Autocrine Role of Basic Fibroblast Growth Factor (bFGF) in Angiogenesis and Angioproliferative Diseases (1998) (0)
- Inflammation and tumor progression: role of prostaglandin E2 pathway (2013) (0)
- Safety of Anti-Angiogenic Drugs in Pediatric Patients with Solid Tumors: A Systematic Review and Meta-Analysis (2022) (0)
- Endothelial cell growth and migration and in vivo angiogenesis promoted by substance P are mediated by nitric oxide (1995) (0)
- Interaction of Neutrophils with Endothelial Cells, Fibroblasts and Their Extracellular Matrices: Microscopic and Computerised Analysis (1988) (0)
- Angiogenesis factor(s) activity can be modulated by gangliosides (1988) (0)
- Sodium nitroprusside stimulates mobilization and urokinase activity in coronary post-capillary endothelial cells (1995) (0)
- Synergic antitumor activity of DPE, a polyphenol of extra virgin olive oil, and cetuximab in colon cancer (2010) (0)
- Angiogenesis of cutaneous melanoma: 168 (1993) (0)
- Novel tyrosine kinase inhibitors active against a wide panel of tumor cell lines (2006) (0)
- REAL TIME RT-PCR VEGF mRNA EXPRESSION AND ERK1 EXPRESSION AND ACTIVITY IN RENAL TUMORS (1999) (0)
- Angiotensin II potentiates the mitogenic effect of noradrenaline in vascular smooth muscle cells via AT1 receptors (2001) (0)
- Syndecan-4/PKCα pathway mediates Prostaglandin E 2 -induced ERK activation in endothelial cells and angiogenesis in vivo* (2013) (0)
- Funding Italian Research (1995) (0)
- Role of scaffold molecules KSRs in cell migration and angiogenesis (2010) (0)
- Activity of "NO-donor" or "NO-mediated" drugs. (2001) (0)
- Angiogenesis in Hepatocellular Carcinoma Cell Lines Induced − Synthase Are Involved in Multidrug Resistance Hepatocyte Growth Factor and Inducible Nitric Oxide (2006) (0)
- Angiogenesis as a marker of neoplastic transformation. Abstr. (1981) (0)
- Substance P stimulates migration of cultured human skin fibroblasts (1995) (0)
- Cancer esearch apeutics , Targets , and Chemical Biology inoflavone , a Ligand of the Aryl Hydrocarbon Receptor , R bits HIF-1 α Expression in an AhR-Independent Fashion (2010) (0)
- Biology and physiopathology of angiogenesis: the 1997 Philippe Laudat Conference (2004) (0)
- Aldehyde Dehydrogenase 2 regulates senescence in the vascular endothelium (2016) (0)
- Abstract 465: CEACAM-1 is a Key Regulator of Endothelial Proliferation and Migration in vitro and in vivo via FAK Dependent Proteasomal Degradation of FOXO Transcription Factors and Metalloproteinase Secretion (2006) (0)
- Biological characterization of nanocomposite hydrogels (2013) (0)
- Plasminds containing multiple competitors and their application for angiogenic factor quantification (Angiobalance) (1999) (0)
- Low concentration of cetuximab treatment combined with DPE, a polyphenol of extra virgin olive oil, reduces colorectal cancer cell growth (2013) (0)
- Abstract P3-14-08: Preclinical and clinical evidence about the use of betablockers for the treatment of triple negative breast cancer: A systematic review (2019) (0)
- Effect of CP96,345 on substance P and [Sar9]-SP-sulfone induced proliferation and inositol phosphate mobilization in human skin fibroblasts (1994) (0)
- Development and validation of a case-finding algorithm for the identification of non-small cell lung cancers in a region-wide Italian pathology registry (2022) (0)
- 494: Prostaglandin E2 trans-activates the Colony-Stimulating Factor-1 (CSF-1) receptor and synergizes with CSF-1 in the induction of cell migration in macrophages via the mitogen-activated protein kinase ERK1/2 (2014) (0)
- Role of Gangliosides in the Modulation of the Angiogenic Response (1993) (0)
- Abstract 723: Vimentin Provides The Essential Scaffold For Pkg Mediated Vasp Phosphorylation Necessary For Endothelial Migration And Proliferation (2007) (0)
- Calcium mobilization and inositol phosphate metabolism in coronary endothelial cells in response to bradykinin (1992) (0)
- Trophic role of neurokininson in vitro models (1990) (0)
- Abstract 1130: mPGES-1 drives the oncogenic potential of EGFR signaling (2011) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Marina Ziche?
Marina Ziche is affiliated with the following schools:
